What Trump's reclassification of pot and CBD could mean for seniors, research and stocks
Reclassification to a Schedule III drug and possible Medicare coverage for pot could unlock new investment from pharmaceutical companies.
Source link
Get latast news super fast
Reclassification to a Schedule III drug and possible Medicare coverage for pot could unlock new investment from pharmaceutical companies.
Source link